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Abstract Human papillomaviruses (HPVs) are a very
complex group of pathogenic viruses, with more than 80
types, causing human infection. Given the prevalence of
HPV infection and its relationship with the development of
cervical and many other cancers, HPV vaccine develop-
ment has been a major public health initiative worldwide in
the last decade. The aim of the presented study was to
identify HPV DNA by MY-PCR in 4,150 school children
and adolescents, aged 10–18 years in the Wielkopolska
region, Poland. All individuals were asked to fill in
extensive questionnaires; further normal, oral squamous
cells were collected from each pupil. Cellular DNA was
isolated and used as a MY-PCR template to estimate the
incidence of HPV-active infection. Forty five subjects
(1.08% of the sample) were carriers of oropharyngeal
HPVs. HPV status and variables of interest, such as age,
gender, socioeconomical status, and risk factors (smoking
and sexual intercourse history, alcohol consumption) were
not correlated. The presence of HPVs in the oral cavity was
cumulated in several schools of the region. DNA sequencing
of MY-PCR products revealed only four HPV genotypes. The
most frequent genotype was HPV11 (38/45 HPV-positive
cases), while other more rare genotypes were HPV6 (3/45),
HPV12 (3/45), and HPV57 (1/45). Conclusion: Our findings
presented herein, reveal a relatively low prevalance of
oropharyngeal HPVs in Polish adolescents and fill an
important gap in the knowledge of oral HPV infections of
children above 10 years and adolescents.
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Introduction
Human papillomaviruses (HPVs) are small double-stranded
DNA tumor viruses infecting oral mucosa and genital
tracts; many HPV genotypes are found in both these
localizations. HPVs responsible for benign epithelial hyper-
proliferation are named “low-risk” types (HPV-LR), while
HPVs associated with premalignant lesions and invasive
squamous cell carcinoma are named “high-risk” types
(HPV-HR) [5, 23]. In the head and neck, HPV infections
may result in benign lesions of the oral cavity and larynx or
in squamous cell carcinoma in the oropharynx [8]. HPVs
are not only found in cancer tissues but also detected in
normal oral mucosa of healthy individuals [15]. Although
HPV infection is transmitted mainly by sexual contacts, it
may also be transmitted by skin-to-skin contacts [18]. It has
been proposed that HPV infection of normal skin is
acquired very early in infancy [1]. Several modes of HPV
transmission during birth were proposed by birth canal,
transplacental infection or amniotic fluid [20]. In the oral
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DOI 10.1007/s00431-010-1345-xcavity, 24 HPV genotypes (HPV-1, 2, 3, 4, 6, 7, 10, 11, 13,
16, 18, 30, 31, 32, 33, 35, 45, 52, 55, 57, 59, 69, 72 and 73)
have been shown to be present in benign lesions and 12
HPV genotypes (HPV-2, 3, 6, 11, 13, 16, 18, 31, 33, 35, 52
and 57) in malignant lesions [9]. According to Syrjanen et
al. the list of HPV genotypes found in the oral cavity is
even longer and includes also HPV-58 genotype [21]. Many
reports about oral HPV prevalence in the oropharynx in
geographically distant human populations are available
from cross-sectional surveys [3, 10, 17, 19, 20, 22].
However, different methodological approaches make difficult
to compare HPV frequencies and patterns of HPV genotypes
in normal oral mucosa among studied groups. Therefore,
HPV prevalence varies from one study to another and remains
controversial [4].
It should be noted that there are very few population-based
screening programs restricted to small areas in Poland [2].
The purpose of the present study was to investigate the
prevalence and genotypes of HPV in the oral cavity of
children and adolescents in the Wielkopolska region, Poland.
It is the first epidomiological cross-sectional survey con-
ducted in children and adolescents in Poland. Our data
provide novel information, still missing in Poland [11], about
HPV occurrence in the oral cavity/oropharynx in young
Polish population, aged 10–18.
Materials and methods
Sampling design
Data were collected in years 2008–2009 as part of a large
ongoing cross-sectional population-based survey of adoles-
cents in the Wielkopolska region named ADOPOLNOR
(www.adopolnor.eu). This region, with 3.4 million popula-
tion, is situated in the central west of Poland and covers
29,826.51 km
2. The study population consisted of 2,028 boys
and 2,122 girls, aged 10–18 years, pupils of all types of
schools, residing in rural and urban areas of the Wielkopolska
region. The examination included body height and weight
measurements and an extensive questionnaire where adoles-
cents reported their state of health, health-risk behaviours,
such as smoking cigarettes, drinking alcohol, taking drugs,
and practicing risky sexual activities and socioeconomic life
conditions of their households.
Biological samples—collection and preparation
Oral squamous cells from all the studied subjects (n=4150)
were collected as an oral rinse with a saline solution (5 mL)
and processed to cellular DNA extraction, as previously
described [7]. DNA concentration obtained from buccal
swabs ranged from 10 to 30 ng/ul.
Detection of HPV DNA by MY-PCR, sequencing
and preparation of DNA standards
All these steps were performed as described in previous
studies [6, 13].
Statistical analyses
For statistical analysis, all subjects were grouped by age
(10–12; 13–15, and 16–18 years), type of school, and
residence. The urbanization factor was categorized as
follows: place of residence—village (up to 20,000 residents),
town (up to 500,000 residents), and city (over 500,000
residents). The school type was classified into primary, lower
secondary, and higher secondary.
ThePearson's chi-square test was used to estimate relation
between HPV prevalence and variables of interest. Compu-
tations were performed using the Statistica 7.1 software
package (StatSoft. Inc. 2005 Statistica for Windows).
Statistical decisions were taken with a 5%-error probability.
Results
The study sample included 4,150 children and adolescents
of caucasian race. This racial homogeneity is typical for
Polish population and relatively rare in the world. There
were slightly more girls than boys in the study sample
(51.13% versus 48.87%). For more detailed description of
sociodemographic data of the participants evaluated in the
investigation, refer to Table 1.
The total prevalence of HPV in the oral cavity was
1.08% and four different HPV genotypes were detected.
More HPV-positive individuals were among girls (53.3%).
No correlation was found between HPV prevalence and
diseases of upper respiratory tract diagnosed by clinicians
in the study group (including chronic diseases, such as
asthma, tuberculosis, mucoviscidosis; these variables were
not included in Table 2). The distribution of positive cases
for infections with HPV was almost even as far as the
different sizes of places of residence in the Wielkopolska
region is concerned. For details, see Table 2. Correlations
between HPV prevalence in the oral cavity and age, gender,
socioeconomical status, as well as several risk factors
enhancing HPV-related cell transformation, as described in
literature (smoking, alcohol consumption, and sexual
intercourse history), were sought, but none was observed.
Smoking and alcohol consumption categories were not
included in Table 2.
After the initial MY-PCR amplification, over 53 samples
could be classified as positive for HPV DNA presence. In
order to confirm these results, a second round of MY-PCR
was performed; eight probes were negative for the presence
758 Eur J Pediatr (2011) 170:757–761of 450-bp HPV amplicon and were excluded from further
analysis to avoid overestimation of positive results. It might
have been due to the lack of viral DNA stability and/or too
low viral DNA copy numbers very close to the detection
threshold using MY-PCR method. In any case, the 450-bp
HPV amplicon was redetected in 45 probes. The presence
of HPV DNA was additionally confirmed and checked for
HPV genotypes by direct DNA sequencing from PCR
reaction tube (without purification from MY09 and MY11
oligonucleotides), even though the ethidium bromide signal
from the 450-bp HPVamplicon had been very weak (hardly
visible) in agarose gel after electrophoresis of several
probes. In general, “seq files” contained sequences of
perfect readability covering over 300–400 nucleotides; in
three cases, only 50–100 nucleotides could have beed read
because of numerous “N” nucleotides (background noise).
With the help of the corresponding chromatogram file, they
were easily corrected. In either case, assigning HPV
genotype to each sequence was possible.
In our study group, none of HPV-HR types was detected,
while among HPV-LR types, HPV-11 (38/45 HPV-positive
cases), HPV-6 (3/45 HPV-positive cases), HPV-57 (3/45
Table 1 General characteristics of the study sample
Variables Number %
Gender Boys 2,028 48.87
Girls 2,122 51.13
Age (years) 10–12 (primary school) 1,313 31.64
13–15 (secondary school) 1,551 37.37
16–18 (high school) 1,286 30.99
Place of residence
a Village 1,603 38.63
Town: 21,000–500,000 inhabitants 1,675 40.36
City over 500,000 inhabitants 807 19.45
Socio-economic status (SES)—on the basis of complex indicator)
b Low 1,338 32.24
Average 1,301 31.35
High 1,401 33.76
Sexual intercourse
c No 2,356 86.52
Yes, once 103 3.78
Yes, more than once 264 9.69
a65 individuals did not state their place of residence (blank space in the questionnaire)
bOne hundred and ten individuals did not state their SES (blank space in the questionnaire)
cOnly adolescents (13–15 and 16–18 age categories) were asked with question about sexual intercourse (N=2,837). 114 individuals did not want to answer
this question (blank space in the questionnaire), thus N=2,723 in this category
Table 2 HPV prevalence and selected features of the study sample
Variables Category Number of HPV-infected individuals Chi-square df P value
Gender Boys 21 0.086 1 0.7690
Girls 24
Age 10–12 9 3.56 2 0.1685
13–15 22
16–18 14
Place of residence Village: up to 20,000 inhabitants 13 5.595 2 0.0610
Town: 21,000–500,000 inhabitants 17
City: over 500,000 inhabitants 15
SES Low 13 0.41 2 0.8150
Average 16
High 16
Sexual intercourse* No 34 2.29 2 0.3180
Yes, once 0
Yes, more than once 2
*Only adolescents (13–15 and 16–18 age categories) were asked with question about sexual intercourse (N=2,837). 114 individuals did not want
to answer this question (blank space in the questionnaire), thus N=2,723 in this category
Eur J Pediatr (2011) 170:757–761 759HPV-positive cases), and HPV-12 (1/45 HPV-positive
cases) were found (Table 3).
Discussion
A great variation in HPV rates detected in the oral mucosa
of healthy individuals was reported, and it depends on the
population studied and the choice of method. It is also
known that HPV occurrence in the normal oral mucosa
comprises sublinical and/or latent infections; Moreover,
HPV infections of low viral load are frequent in the oral
cavity [4]. Given the abundance of literature describing
results concerning HPV prevalence in the oral cavity and
oropharynx all over the world, data presented in this study
are to be compared to similar surveys, which were
conducted on adolescents aged 10–18 years old using the
same MY-PCR method.
In the present study, HPV-11 genotype was detected at
surprisingly high rate (38/45 HPV-positive cases), while
HPV-6 type, frequently reported to be present in the
oropharynx, was detected only in three cases (3/45 HPV-
positive cases). In our concurrent study, HPV-6 genotype
has been identified in 30% cases of juvenile-onset recurrent
respiratory papillomatosis among 47 patients investigated
(3–12 year old) [6]. Concordant results concerning high
HPV-11 prevalence in normal oral mucosa were not
reported in literature. One should keep in mind that in
some cases, localized HPV-11 infection may lead to severe
clinical symptoms, such as recurrent respiratory papilloma-
tosis mentioned above, or genital warts if infection is
transmitted [12]. Another important finding of our study
was the HPV-57 type present in three HPV-positive samples
(3/45 HPV-positive cases). This HPV type had been
previously found in numerous locations (inverted papillomas
of the maxillary sinus, an oral verruca, and a genital
condyloma) [14]. In rare cases, both HPV-11 and HPV−57
types are detected in malignant tumors. HPV-11 is known,
especially for transformation of cells of the larynx and lungs,
while HPV-57 of the nasal cavity.
It was also surprising to detect HPV-12 genotype in one
specimen, because in the majority of studies, it was not
mentioned to infect buccal mucosa [9, 21] and is rather
considered to be etiologically significant in cutaneous
epidermodysplasia verruciformis (EV)-associated HPV
(EV-HPV). However, HPV-12 tends also to persistently
infect within oral mucosa as shown in the study on HPV
prevalence in Japan [10].
In the present study HPV-HR genotypes were not
detected, whereas their presence was reported at relatively
high rate in similar studies by other researchers [19, 20]. It
may be due to the MY-PCR method, solely employed in
our experimental procedure. It has been reported that type-
specific nested PCR greatly improves detection limit of
HPV-16 in buccal samples, setting it below ten viral DNA
copies [16]. However, in one study performed with the sole
usage of MY09 and MY11 oligonucleotides in PCR
reaction, HPV-16 DNA was detected in one sample (among
662 screened). The detection limit was set at 100 viral
copies in that study [10]. These results could support ours,
in which case, indeed HPV-HR types were not present in
the study sample of Polish adolescents or HPV-HR DNA
load was significantly lower (several viral copies) than the
viral load of detected HPV-LR genotypes.
The overall HPV prevalence in the study group was
1.08%, and its distribution was even among different strata
of age. This observation remains in opposition to those
from other studies establishing that HPV prevalence
depends strongly upon age [19]. Whereas the HPV
prevalence reported herein is low and consistent with the
results mentioned above; where the mean HPV prevalence
in the 12–15 year-old group of American adolescents was
1.5% [19].
In the present study correlations between HPV, preva-
lence and other variables were not observed. Concordant
results were described in a number of studies [19, 20];
where sociodemographic gender, sexual intercourse (only
adolescents over 13 years old were asked the question
about their sexual activity), smoking cigarettes, and
drinking were taken into account. In our study correlation
of HPV, prevalence with upper respiratory chronic diseases
(such as asthma, tuberculosis, mucoviscidosis) was also
sought but was not observed. However, it is noteworthy
that in several schools, localized in small towns around
Poznań and in Poznań itself, the number of HPV-positive
children/adolescents was elevated (not included in Table 2).
HPV genotype N (HPV-positive cases) % (out of N=4,150) HPV genotype/all HPV cases
HPV11 38 0.92 38/45
HPV6 3 0.07 3/45
HPV57 3 0.07 3/45
HPV12 1 0.02 1/45
All HPV cases 45 1.08
Table 3 Prevalence of HPV
genotypes in the study
sample
760 Eur J Pediatr (2011) 170:757–761A non-invasive method for oral squamous cells collec-
tion, DNA extraction, and HPV DNA detection described
herein are suitable for large cross-sectional studies of
children and adolescents.
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